375
Views
33
CrossRef citations to date
0
Altmetric
Original Articles

Natural Grape Extracts Regulate Colon Cancer Cells Malignancy

, , , , , , , & show all
Pages 494-503 | Received 19 May 2014, Accepted 18 Nov 2014, Published online: 23 Feb 2015

REFERENCES

  • Nakajima S, Doi R, Toyoda T, Tsuji S, and Wada M: N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma. Clin Cancer Res, 10, 4125–4133, 2004.
  • Signorelli P, Munoz-Olaya JM, Gagliostro V, Casas J, and Ghidoni R: Dihydroceramide intracellular increase in response to resveratrol treatment mediates autophagy in gastric cancer cells. Cancer Lett 282, 238–243, 2009.
  • Gonzalez-Gallego J, Garcia-Mediavilla MV, Sanchez-Campos S, and Tuñón MJ: Fruit polyphenols, immunity and inflammation. Br J Nutr 104, S15–S27,, 2010.
  • Granci V, Dupertuis YM, and Pichard C: Angiogenesis as a potential target of pharmaconutrients in cancer therapy. Curr Opin Clin Nutr Metab Care 13, 417–422, 2010.
  • Yang CS, Wang X, and Lu G: Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer 9, 429–439, 2009.
  • Signorelli P and Ghidoni R: Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. J Nutr Biochem 16, 449–466, 2005.
  • Scarlatti F, Sala G, Ricci C, et al.: Resveratrol sensitization of DU145 prostate cancer cells to ionizing radiation is associated to ceramide increase. Cancer Lett 253, 124–130, 2007.
  • Tyagi AK, Singh RP, Agarwal C, et al.: Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis. Clin Cancer Res 8, 3512–3519, 2002.
  • Lea MA, Ibeh C, Han L, et al.: Inhibition of growth and induction of differentiation markers by polyphenolic molecules and histone deacetylase inhibitors in colon cancer cells. Anticancer Res 30, 311–318, 2010.
  • Lemos T, Verdoorn KS, Nogaroli L, et al.: Biphasic regulation of type II phosphatidylinositol-4 kinase by sphingosine: Cross talk between glycero- and sphingolipids in the kidney. Biochim Biophys Acta, 1838, 1003-1009, 2014.
  • Sukocheva OA and Wadham C: Role of sphingolipids in estrogen signalling in breast cancer cells: an update. J Endocrinol, 220, R22-35, 2014.
  • Scarlatti F, Sala G, Somenzi G, et al.: Resveratrol induces growth inhibition and apoptosis in metastatic breast cancer cells via de novo ceramide signaling. FASEB J 17, 2339–2341, 2003.
  • Park K, Lee S, and Lee YM: Sphingolipids and antimicrobial peptides: function and roles in atopic dermatitis. Biomol Ther (Seoul) 21, 251–257, 2013.
  • Ernst AM and Brugger B: Sphingolipids as modulators of membrane proteins. Biochim Biophys Acta, 1841, 665-670, 2014.
  • Schulze H and Sandhoff K: Sphingolipids and lysosomal pathologies. Biochim Biophys Acta, 134(5), 1359-1368, 2014.
  • Dolfini E, Roncoroni L, Dogliotti E, et al.: Resveratrol impairs the formation of MDA-MB-231 multicellular tumor spheroids concomitant with ceramide accumulation. Cancer Lett 249, 143–147, 2007.
  • Delmas D, Solary E, and Latruffe N: Resveratrol, a phytochemical inducer of multiple cell death pathways: apoptosis, autophagy and mitotic catastrophe. Curr Med Chem 18, 1100–1121, 2011.
  • Fremont L: Biological effects of resveratrol. Life Sci 66, 663–673, 2000.
  • Pervaiz S: Resveratrol: from grapevines to mammalian biology. FASEB J 17, 1975–1985, 2003.
  • Kang NJ, Shin SH, Lee H J, et al.: Polyphenols as small molecular inhibitors of signaling cascades in carcinogenesis. Pharmacol Ther 130, 310–324, 2011.
  • Danilenko M, Wang Q, Wang X, et al.: Carnosic acid potentiates the antioxidant and prodifferentiation effects of 1alpha,25-dihydroxyvitamin D3 in leukemia cells but does not promote elevation of basal levels of intracellular calcium. Cancer Res 63, 1325–1332, 2003.
  • Sharabani H, Izumchenko E, Wang Q, et al.: Cooperative antitumor effects of vitamin D3 derivatives and rosemary preparations in a mouse model of myeloid leukemia. Int J Cancer 118, 3012–3021, 2006.
  • Shabtay A, Sharabani H, Barvish Z, et al.: Synergistic antileukemic activity of carnosic acid-rich rosemary extract and the 19-nor Gemini vitamin D analogue in a mouse model of systemic acute myeloid leukemia. Oncol 75, 203–214, 2008.
  • Zhang J, Harrison JS, Uskokovic M, et al.: Silibinin can induce differentiation as well as enhance vitamin D3-induced differentiation of human AML cells ex vivo and regulates the levels of differentiation-related transcription factors. Hematol Oncol 28, 124–132, 2010.
  • Iida K, Itoh K, Kumagai Y, et al.: Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis. Cancer Res 64, 6424–6431, 2004.
  • Rangasamy T, Guo J, Mitzner WA, et al.: Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice. J Exp Med 202, 47–59, 2005.
  • Fahey JW, Haristoy X, Dolan PM, et al.: Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors. Proc Natl Acad Sci USA;99, 7610–7615, May 28, 2002.
  • Khor TO, Huang MT, Kwon KH, et al.: Nrf2-deficient mice have an increased susceptibility to dextran sulfate sodium-induced colitis. Cancer Res 66, 11580–11584, 2006.
  • Chen W, Sun Z, Wang XJ, et al.: Direct interaction between Nrf2 and p21(Cip1/WAF1) upregulates the Nrf2-mediated antioxidant response. Mol Cell 34, 663–673, 2009.
  • Villeneuve NF, Sun Z, Chen W, et al.: and p21 regulate the fine balance between life and death by controlling ROS levels. Cell Cycle 8, 3255–3256, 2009.
  • Zhao F, Wu T, Lau A, et al.: Nrf2 promotes neuronal cell differentiation Free Radic Biol Med 47, 867–879, 2009.
  • Kosaka K, Mimura J, Itoh K, et al.: Role of Nrf2 and p62/ZIP in the neurite outgrowth by carnosic acid in PC12h cells. J Biochem 147, 73–81, Jan, 2010.
  • Pi J, Leung L, Xue P, et al.: Deficiency in the nuclear factor E2-related factor-2 transcription factor results in impaired adipogenesis and protects against diet-induced obesity. J Biol Chem 285, 9292–9300, 2010.
  • Bobilev I, Novik V, Levi I, et al.: The Nrf2 transcription factor is a positive regulator of myeloid differentiation of acute myeloid leukemia cells. Cancer Biol Ther 11, 317–329, 2011.
  • Perletti G, Marras E, Dondi D, et al.: p21(Waf1/Cip1) and p53 are downstream effectors of protein kinase C delta in tumor suppression and differentiation in human colon cancer cells. Int J Cancer 113, 42–53, 2005.
  • Li Y, Paonessa JD, and Zhang Y: Mechanism of chemical activation of Nrf2. PLoS One 7, e35122, 2012.
  • Kensler TW, Curphey TJ, Maxiutenko Y, et al.: Chemoprotection by organosulfur inducers of phase 2 enzymes: dithiolethiones and dithiins. Drug Metabol Drug Interact 17(1–4), 3–22, 2000.
  • Balogun E, Hoque M, Gong P, et al.: Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem J 371, 887–895, 2003.
  • Garg R, Gupta S, and Maru GB: Dietary curcumin modulates transcriptional regulators of phase I and phase II enzymes in benzo[a]pyrene-treated mice: mechanism of its anti-initiating action. Carcinogenesis; 29, 1022–1032, 2008.
  • Kode A, Rajendrasozhan S., Caito S, et al.: Resveratrol induces glutathione synthesis by activation of Nrf2 and protects against cigarette smoke-mediated oxidative stress in human lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 294, L478–L488, 2008.
  • Chen CY, Jang JH, Li MH, et al.: Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells. Biochem Biophys Res Commun 331, 993–1000, 2005.
  • Shu L, Cheung KL, Khor TO, et al.: Phytochemicals: cancer chemoprevention and suppression of tumor onset and metastasis. Cancer Metastasis Rev 29, 483–502, 2010.
  • Iiizumi M, Liu W, Pai K, et al.: Drug development against metastasis-related genes and their pathways: a rationale for cancer therapy. Biochim Biophys Acta 1786, 87–104, 2008.
  • Canals D and Hannun YA: Novel chemotherapeutic drugs in sphingolipid cancer research. Handb Exp Pharmacol, 215, 211–238, 2013.
  • Kraveka JM, Li L, Szulc ZM, et al.: Involvement of dihydroceramide desaturase in cell cycle progression in human neuroblastoma cells. J Biol Chem 282, 16718–16728, 2007.
  • Benzie IF and Strain JJ: The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem 239, 70–76, 1996.
  • Zarban A, Taheri F, Chahkandi T, et al.: Antioxidant and radical scavenging activity of human colostrum, transitional and mature milk. J Clin Biochem Nutr. 45, 150–154, 2009.
  • Aruoma OI: Nutrition and health aspects of free radicals and antioxidants. Food Chem Toxicol 32, 671–683, 1994.
  • Munoz-Olaya JM, Matabosch X, Bedia C, et al.: Synthesis and biological activity of a novel inhibitor of dihydroceramide desaturase. ChemMedChem 3, 946–953, 2008.
  • Nautiyal J, Kanwar SS, Yu Y, et al.: Combination of dasatinib and curcumin eliminates chemo-resistant colon cancer cells. J Mol Signal 6, 7, 2011.
  • Arocho A, Chen B, Ladanyi M, et al.: Validation of the 2-DeltaDeltaCt calculation as an alternate method of data analysis for quantitative PCR of BCR-ABL P210 transcripts. Diagn Mol Pathol 15, 56–61, 2006.
  • Gagliostro V, Casas J, Caretti A, et al.: Dihydroceramide delays cell cycle G1/S transition via activation of ER stress and induction of autophagy. Int J Biochem Cell Biol 44, 2135–2143, 2012.
  • Taguchi K, Motohashi H, and Yamamoto M: Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Genes Cells 16, 123–140, 2011.
  • Zhang M, Liu Y, Feng H, et al.: CD133 affects the invasive ability of HCT116 cells by regulating TIMP-2. Am J Pathol 182, 565–576, 2013.
  • Peinado H, Olmeda D, and Cano A: Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7, 415–428, 2007.
  • Uchikado Y, Natsugoe S, Okumura H, et al.: Slug Expression in the E-cadherin preserved tumors is related to prognosis in patients with esophageal squamous cell carcinoma. Clin Cancer Res 11, 1174–1180, 2005.
  • Connor KM, Hempel N, Nelson KK, et al.: Manganese superoxide dismutase enhances the invasive and migratory activity of tumor cells. Cancer Res 67, 10260–10267, 2007.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.